Published in J Clin Oncol on March 01, 1998
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol (2010) 1.41
The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr (2010) 1.26
National Collaborative to Improve Oncology Practice: The National Cancer Institute Community Cancer Centers Program Quality Oncology Practice Initiative Experience. J Oncol Pract (2009) 1.26
Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline. BMC Cancer (2004) 1.02
Locoregional therapy of locally advanced breast cancer: a clinical practice guideline. Curr Oncol (2015) 1.01
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline. BMC Cancer (2004) 0.96
The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery. BMC Surg (2008) 0.93
Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines. BMC Med Res Methodol (2005) 0.93
Clinical practice guideline on the optimal radiotherapeutic management of brain metastases. BMC Cancer (2005) 0.92
Alemtuzumab in chronic lymphocytic leukemia. Curr Oncol (2007) 0.91
Challenges in knowledge translation: the early years of Cancer Care Ontario's Program in Evidence-Based Care. Curr Oncol (2012) 0.90
Liver resection for colorectal cancer metastases. Curr Oncol (2013) 0.89
Clinician-patient communication: evidence-based recommendations to guide practice in cancer. Curr Oncol (2009) 0.88
Invasive mediastinal staging of non-small-cell lung cancer: a clinical practice guideline. Curr Oncol (2011) 0.88
Single-agent interleukin-2 in the treatment of metastatic melanoma. Curr Oncol (2007) 0.85
Safe handling of parenteral cytotoxics: recommendations for ontario. J Oncol Pract (2009) 0.84
Follow-up for women after treatment for cervical cancer. Curr Oncol (2010) 0.82
'Background to clinical guidelines in cancer': SOR, a programmatic approach to guideline development and aftercare. Br J Cancer (2001) 0.82
Can surveying practitioners about their practices help identify priority clinical practice guideline topics? BMC Health Serv Res (2003) 0.81
Clinicians' evaluations of, endorsements of, and intentions to use practice guidelines change over time: a retrospective analysis from an organized guideline program. Implement Sci (2009) 0.81
Creating computable algorithms for symptom management in an outpatient thoracic oncology setting. J Pain Symptom Manage (2013) 0.80
Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline. Curr Oncol (2006) 0.78
What is the Best Way to Produce Consensus and Buy in to Guidelines for Rectal Cancer? Curr Colorectal Cancer Rep (2012) 0.76
Optimal systemic therapy for early breast cancer in women: a clinical practice guideline. Curr Oncol (2015) 0.76
Health care use and risk of ovarian cancer: is there a link? CMAJ (2007) 0.75
Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario. Curr Oncol (2016) 0.75
Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer. Curr Oncol (2017) 0.75
Safe handling of cytotoxics: guideline recommendations. Curr Oncol (2015) 0.75
Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline. Curr Oncol (2016) 0.75
Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline. Curr Oncol (2016) 0.75
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. J Natl Cancer Inst (2009) 4.24
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol (2005) 3.62
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med (1993) 3.61
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med (1997) 3.57
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet (1994) 3.51
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Limitations of impedance plethysmography in the diagnosis of clinically suspected deep-vein thrombosis. Ann Intern Med (1993) 3.40
The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol (1988) 2.91
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Prevention of venous thromboembolism. Chest (1995) 2.69
A standard heparin nomogram for the management of heparin therapy. Arch Intern Med (1991) 2.69
Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol (2006) 2.66
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol (2014) 2.50
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer (1999) 2.36
Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction. CMAJ (2000) 2.32
Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol (1999) 2.29
Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol (1989) 2.22
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
A comparison of the costs of paclitaxel and best supportive care in stage IV non-small-cell lung cancer. Cancer Prev Control (1997) 2.08
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med (1998) 2.03
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer (2004) 1.94
Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol (1999) 1.92
Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol (1996) 1.91
Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst (1992) 1.87
Prevention of venous thromboembolism. Chest (1992) 1.81
Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol (1992) 1.77
Low molecular weight heparin. Blood (1992) 1.74
Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol (1986) 1.73
Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. J Clin Oncol (1992) 1.72
Attitudes of terminally ill patients toward euthanasia and physician-assisted suicide. Arch Intern Med (2000) 1.68
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol (1995) 1.66
Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold? Ann Oncol (2011) 1.64
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br J Cancer (2012) 1.64
A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion (1992) 1.62
Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer (2000) 1.61
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck (2001) 1.61
The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet (2006) 1.52
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol (1984) 1.51
Studies on the pathogenesis of alcohol-induced sideroblastic bone-marrow abnormalities. N Engl J Med (1970) 1.47
The effect of ethanol on hemostatic properties of human blood platelets. Am J Med (1974) 1.44
The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ (2001) 1.44
Systemic adjuvant therapy for node-negative breast cancer. CMAJ (1989) 1.42
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol (1989) 1.42
AmpFlSTR Profiler Plus and AmpFlSTR COfiler analysis of tissues stored in GenoFix, a new tissue preservation solution for mass disaster DNA identification. J Forensic Sci (2001) 1.41
Improving prevention in primary care: evaluating the effectiveness of outreach facilitation. Fam Pract (2008) 1.40
Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation. BMJ Qual Saf (2011) 1.39
Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. Ann Oncol (1992) 1.39
The HER-2/neu oncogene in breast cancer: so what is new? J Clin Oncol (1992) 1.39
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38
Effect of alcoholism on hemostasis. Semin Hematol (1980) 1.37
Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art. Curr Oncol (2012) 1.37
The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer (1997) 1.35
Epidemiology of thrombosis in cancer. Acta Haematol (2001) 1.33
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol (1987) 1.31
The prevalence and scope of urinary incontinence. Clin Geriatr Med (1986) 1.31
VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol (1985) 1.30
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med (1985) 1.28
Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol (1987) 1.27
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet (1987) 1.25
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Ann Oncol (2008) 1.24
Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.23
Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic. Ann Oncol (2002) 1.21
A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol (1987) 1.19
The influence of morphology on prognosis in acute leukemia. Can Med Assoc J (1967) 1.17
Migration of human vascular endothelial and smooth muscle cells. Lab Invest (1979) 1.16
Neurologic disorders in patients with small cell lung cancer. Cancer (1987) 1.15
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients. Ann Oncol (2010) 1.14
Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer (2000) 1.13
High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four cases. Lung Cancer (1994) 1.13
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost (2010) 1.12
Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg (1991) 1.12
Hemorrhagic complications of anticoagulant therapy. Semin Thromb Hemost (1986) 1.10
Hemorrhagic complications of anticoagulant treatment. Chest (1995) 1.10
A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int (2008) 1.09
Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions. Eur J Cancer (2001) 1.08
Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers. CMAJ (1989) 1.08
Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial. Ann Intern Med (1987) 1.08
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer. J Clin Oncol (1985) 1.08
Poor clinical response to enteric-coated iron preparations. CMAJ (1989) 1.07
Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271). Cancer Chemother Rep (1976) 1.07
The standardization of NK cell assays for use in studies of biological response modifiers. J Immunol Methods (1984) 1.06
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oncol (1991) 1.06